Trial Profile
Clopidogrel Proton-Pump Inhibitors Study.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Omeprazole (Primary) ; Pantoprazole (Primary) ; Clopidogrel
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- 19 Oct 2016 Status changed from suspended to withdrawn prior to enrolment since the published data resolved the study goals we decided not to start it.
- 23 Jun 2011 Planned end date changed from 1 Feb 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 23 Jun 2011 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.